WithdrawnPhase 2NCT00746980

Efalizumab in the Treatment of Alopecia, Phase II

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northwestern University
Principal Investigator
Dennis West, PhD
Northwestern University, Department of Dermatology
Intervention
efalizumab(drug)
Eligibility
18-40 years · All sexes
Timeline
20082009

Collaborators

Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00746980 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials